$ICN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VALEANT PHARMACEUTICALS INTERNATIONAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VALEANT PHARMACEUTICALS INTERNATIONAL. Get notifications about new insider transactions in VALEANT PHARMACEUTICALS INTERNATIONAL for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2005 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 21.07 | 5,695 | 119,994 | 20,804 | 15.1 K to 20.8 K (+37.69 %) |
May 26 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 21.07 | 5,695 | 119,994 | 22,783 | 17.1 K to 22.8 K (+33.33 %) |
May 26 2005 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 21.07 | 5,695 | 119,994 | 12,512 | 6.8 K to 12.5 K (+83.54 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 20.92 | 32 | 669 | 106 | 74 to 106 (+43.24 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 20.92 | 78 | 1,632 | 476 | 398 to 476 (+19.60 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 20.92 | 57 | 1,192 | 343 | 286 to 343 (+19.93 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 20.92 | 57 | 1,192 | 343 | 286 to 343 (+19.93 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 20.92 | 64 | 1,339 | 355 | 291 to 355 (+21.99 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 20.92 | 57 | 1,192 | 343 | 286 to 343 (+19.93 %) |
Apr 29 2005 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 20.92 | 25 | 523 | 95 | 70 to 95 (+35.71 %) |
Apr 04 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 22.57 | 332 | 7,493 | 8,436 | 8.1 K to 8.4 K (+4.10 %) |
Apr 04 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 22.57 | 332 | 7,493 | 17,088 | 16.8 K to 17.1 K (+1.98 %) |
Mar 29 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 22.71 | 33 | 749 | 8,104 | 8.1 K to 8.1 K (+0.41 %) |
Mar 29 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 22.71 | 33 | 749 | 16,756 | 16.7 K to 16.8 K (+0.20 %) |
Mar 02 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 24.25 | 186 | 4,511 | 8,071 | 7.9 K to 8.1 K (+2.36 %) |
Mar 02 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.25 | 247 | 5,990 | 16,723 | 16.5 K to 16.7 K (+1.50 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 25.01 | 66 | 1,651 | 398 | 332 to 398 (+19.88 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 25.01 | 25 | 625 | 74 | 49 to 74 (+51.02 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 25.01 | 48 | 1,200 | 286 | 238 to 286 (+20.17 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 25.01 | 48 | 1,200 | 286 | 238 to 286 (+20.17 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 25.01 | 48 | 1,200 | 286 | 238 to 286 (+20.17 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 25.01 | 52 | 1,301 | 291 | 239 to 291 (+21.76 %) |
Feb 15 2005 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 25.01 | 22 | 550 | 70 | 48 to 70 (+45.83 %) |
Feb 01 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 24.70 | 152 | 3,754 | 7,885 | 7.7 K to 7.9 K (+1.97 %) |
Feb 01 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.70 | 213 | 5,261 | 16,576 | 16.4 K to 16.6 K (+1.30 %) |
Jan 12 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 25.69 | 292 | 7,501 | 7,733 | 7.4 K to 7.7 K (+3.92 %) |
Jan 12 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 26.63 | 63 | 1,678 | 7,441 | 7.4 K to 7.4 K (+0.85 %) |
Jan 12 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 25.69 | 292 | 7,501 | 16,363 | 16.1 K to 16.4 K (+1.82 %) |
Jan 12 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 26.63 | 113 | 3,009 | 16,071 | 16 K to 16.1 K (+0.71 %) |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 23.92 | 251 | 6,004 | 7,378 | 7.1 K to 7.4 K (+3.52 %) |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 23.92 | 408 | 9,759 | 15,958 | 15.6 K to 16 K (+2.62 %) |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 24.18 | 310 | 7,496 | 7,127 | 6.8 K to 7.1 K (+4.55 %) |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.20 | 31 | 750 | 15,550 | 15.5 K to 15.6 K (+0.20 %) |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 24.18 | 310 | 7,496 | 15,519 | 15.2 K to 15.5 K (+2.04 %) |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Option Exercise | A | 23.92 | 80,820 | 1,933,214 | 80,820 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Option Exercise | A | 23.92 | 4,180 | 99,986 | 4,180 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Option Exercise | A | 23.92 | 55,820 | 1,335,214 | 55,820 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Option Exercise | A | 23.92 | 4,180 | 99,986 | 4,180 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 23.92 | 135,820 | 3,248,814 | 135,820 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 23.92 | 4,180 | 99,986 | 4,180 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Option Exercise | A | 23.92 | 395,820 | 9,468,014 | 395,820 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Option Exercise | A | 23.92 | 4,180 | 99,986 | 4,180 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Option Exercise | A | 23.92 | 245,820 | 5,880,014 | 245,820 | |
Nov 30 2004 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Option Exercise | A | 23.92 | 4,180 | 99,986 | 4,180 | |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.51 | 1,142 | 19,996 | 6,817 | 5.7 K to 6.8 K (+20.12 %) |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 17.51 | 1,142 | 19,996 | 20,838 | 19.7 K to 20.8 K (+5.80 %) |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 17.51 | 1,142 | 19,996 | 15,209 | 14.1 K to 15.2 K (+8.12 %) |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 17.51 | 1,142 | 19,996 | 15,209 | 14.1 K to 15.2 K (+8.12 %) |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 17.51 | 1,142 | 19,996 | 1,142 | 0 to 1.1 K |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.51 | 1,142 | 19,996 | 15,209 | 14.1 K to 15.2 K (+8.12 %) |
Sep 15 2004 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 17.51 | 1,142 | 19,996 | 6,817 | 5.7 K to 6.8 K (+20.12 %) |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.62 | 5,675 | 99,994 | 5,675 | 0 to 5.7 K |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 17.62 | 7,946 | 140,009 | 19,696 | 11.8 K to 19.7 K (+67.63 %) |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 17.62 | 5,675 | 99,994 | 14,067 | 8.4 K to 14.1 K (+67.62 %) |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 17.62 | 5,675 | 99,994 | 14,067 | 8.4 K to 14.1 K (+67.62 %) |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 17.62 | 5,675 | 99,994 | 14,067 | 8.4 K to 14.1 K (+67.62 %) |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.62 | 5,675 | 99,994 | 14,067 | 8.4 K to 14.1 K (+67.62 %) |
May 27 2004 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 17.62 | 5,675 | 99,994 | 5,675 | 0 to 5.7 K |
May 13 2004 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Buy | P | 17.82 | 1,000 | 17,820 | 2,000 | 1,000 to 2 K (+100.00 %) |
May 13 2004 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Buy | J | 14.69 | 1,446 | 21,242 | 1,446 | 0 to 1.4 K |
May 11 2004 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Buy | P | 17.94 | 3,000 | 53,820 | 3,000 | 0 to 3 K |
May 11 2004 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Buy | J | 14.69 | 1,446 | 21,242 | 1,446 | 0 to 1.4 K |
May 11 2004 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Buy | P | 18.04 | 6,000 | 108,227 | 18,000 | 12 K to 18 K (+50.00 %) |
May 11 2004 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Buy | J | 14.69 | 1,446 | 21,242 | 1,446 | 0 to 1.4 K |
May 11 2004 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Buy | J | 14.69 | 1,446 | 21,242 | 16,446 | 15 K to 16.4 K (+9.64 %) |
May 11 2004 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Buy | J | 14.69 | 1,446 | 21,242 | 11,796 | 10.4 K to 11.8 K (+13.97 %) |
Mar 16 2004 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Buy | P | 24.64 | 2,000 | 49,280 | 10,350 | 8.4 K to 10.4 K (+23.95 %) |
Mar 11 2004 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Buy | P | 24.89 | 1,800 | 44,802 | 15,000 | 13.2 K to 15 K (+13.64 %) |
Mar 11 2004 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Buy | P | 24.88 | 200 | 4,976 | 13,200 | 13 K to 13.2 K (+1.54 %) |
Mar 15 2004 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Buy | P | 24.66 | 100 | 2,466 | 2,500 | 2.4 K to 2.5 K (+4.17 %) |
Mar 15 2004 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Buy | P | 24.65 | 400 | 9,860 | 2,400 | 2 K to 2.4 K (+20.00 %) |
Mar 10 2004 | ICN | VALEANT PHARMACEUT ... | LEE STEVEN J | Director | Sell | S | 25.75 | 1,000 | 25,754 | 0 | 1,000 to 0 (-100.00 %) |
Mar 10 2004 | ICN | VALEANT PHARMACEUT ... | LEE STEVEN J | Director | Sell | S | 25.70 | 10,000 | 256,985 | 0 | 10 K to 0 (-100.00 %) |
Mar 10 2004 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Buy | P | 25.62 | 2,500 | 64,050 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Dec 15 2003 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Buy | P | 24.53 | 150 | 3,680 | 8,350 | 8.2 K to 8.4 K (+1.83 %) |
Dec 15 2003 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Buy | P | 24.65 | 8,200 | 202,130 | 8,200 | 0 to 8.2 K |
Dec 12 2003 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Buy | P | 24.22 | 1,000 | 24,220 | 1,000 | 0 to 1,000 |
Dec 05 2003 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Buy | P | 25.40 | 2,000 | 50,800 | 13,000 | 11 K to 13 K (+18.18 %) |
Dec 04 2003 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Buy | P | 24.41 | 4,000 | 97,640 | 15,000 | 11 K to 15 K (+36.36 %) |
Dec 05 2003 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Buy | P | 24.91 | 2,500 | 62,275 | 2,500 | 0 to 2.5 K |
Dec 03 2003 | ICN | VALEANT PHARMACEUT ... | LEE STEVEN J | Director | Sell | S | 25.00 | 15,000 | 375,005 | 18,292 | 33.3 K to 18.3 K (-45.06 %) |
Dec 03 2003 | ICN | VALEANT PHARMACEUT ... | LEE STEVEN J | Director | Sell | S | 25.00 | 15,000 | 375,005 | 18,292 | 33.3 K to 18.3 K (-45.06 %) |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | DE VACA CHRISTINA | VP Corp Governance ... | Option Exercise | A | 18.55 | 10,500 | 194,775 | 10,500 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Option Exercise | A | 18.55 | 109,000 | 2,021,950 | 109,000 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Option Exercise | A | 18.55 | 125,440 | 2,326,912 | 125,440 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Option Exercise | A | 18.55 | 21,560 | 399,938 | 21,560 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 18.55 | 218,000 | 4,043,900 | 218,000 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Option Exercise | A | 18.55 | 481,610 | 8,933,866 | 481,610 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | President/ COO | Option Exercise | A | 18.55 | 5,390 | 99,985 | 5,390 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Option Exercise | A | 18.55 | 672,610 | 12,476,916 | 672,610 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Option Exercise | A | 18.55 | 5,390 | 99,985 | 5,390 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Option Exercise | A | 18.55 | 672,610 | 12,476,916 | 672,610 | |
Nov 06 2003 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | CEO & Chairman of t ... | Option Exercise | A | 18.55 | 5,390 | 99,985 | 5,390 | |
Aug 22 2003 | ICN | VALEANT PHARMACEUT ... | ICN PHARMACEUTICALS INC | 10% Owner | Buy | J | 6.25 | 20,729,547 | 129,559,669 | 140,829,547 | 120.1 M to 140.8 M (+17.26 %) |
Aug 14 2003 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Buy | P | 15.01 | 800 | 12,008 | 10,292 | 9.5 K to 10.3 K (+8.43 %) |
Aug 14 2003 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Buy | P | 14.99 | 200 | 2,998 | 9,492 | 9.3 K to 9.5 K (+2.15 %) |
Aug 14 2003 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Buy | P | 15.14 | 1,000 | 15,140 | 11,000 | 10 K to 11 K (+10.00 %) |
Aug 05 2003 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Option Exercise | A | 8.45 | 77,664 | 656,261 | 77,664 | |
Aug 05 2003 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP and General Cou ... | Option Exercise | A | 8.45 | 47,336 | 399,989 | 47,336 | |
Aug 05 2003 | ICN | VALEANT PHARMACEUT ... | DE VACA CHRISTINA | VP Corp Governance ... | Option Exercise | A | 9.28 | 16,900 | 156,832 | 16,900 | |
Aug 05 2003 | ICN | VALEANT PHARMACEUT ... | DE VACA CHRISTINA | VP Corp Governance ... | Option Exercise | A | 9.28 | 43,100 | 399,968 | 43,100 |